Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04254237
Other study ID # 99-B
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 6, 2020
Est. completion date March 30, 2023

Study information

Verified date September 2023
Source Complejo Hospitalario La Mancha Centro
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trocar site hernia is a specific complication of laparoscopic surgery. The increasingly frequent use of the laparoscopic approach has resulted in an increase in the number of hernias, mainly at the umbilical area. The appearance of a trocar site hernia can cause complications in the short and long term to the patient who may end up needing a reoperation. In this study we want to compare the supraumbilical versus the infraumbilical location of the laparoscopy entry trocar, in terms of incisional hernia incidence.


Description:

Trocar site hernias have been considered as an underestimated problem by some surgeons. It's incidence varies in the literature between studies, which may be related to an insufficient diagnosis due to poor clinical manifestation and / or the lack of long-term follow-up of patients in some studies. There are many risk factors that have been related to the trocar site hernia development. On one side, the patient clinical factors as the age, presence of obesity, diabetes mellitus or the smoking habits. On the other side, some risk factors related to the surgical technique have been described, as the entry technique, the size and the locations of the trocars, the fascial closure, the duration of the surgery or the infection of the surgical wound. Regarding the location of the trocars, it seems that the middle line has more risk of incisional hernia than the lateral areas in the abdomen. However, the trocar locations out of the middle line is not always possible, especially in certain surgeries as the laparoscopic cholecystectomy where it can be necessary an expansion of the incision for removing the specimen. In the concrete case of laparoscopic cholecystectomy, the belly is usually the most popular region for placing the first trocar. However, there is not much evidence about the influence of the most popular locations of the umbilical trocar incision (supra or infraumbilical) in the development of incisional hernias. In the middle line, the infraumbilical region presents a great ability to adapt to pressure changes, as it physiologically occurs during the pregnancy. On the other side, while the primary hernias in the supraumbilical and umbilical region are common, these are not produced in the infraumbilical region. Besides, in anatomical studies of the linea alba, a higher thickness of the fibres in the infraumbilical region has been observed, along with a different spatial arrangement, predominating the transverse fibres in the infraumbilical region and the oblique ones in the supraumbilical region. Therefore, we hypothesize whether the infraumbilical location of the trocar in the midline, theoretically a more protected region, can reduce the incidence of trocar site hernia in our patients. The aim of this study is to compare the incidence of the Hasson trocar site hernia between the supra and infraumbilical locations a year after surgery, in high risk patients for trocar site hernia subjected to elective laparoscopic cholecystectomy.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date March 30, 2023
Est. primary completion date March 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Over 18 years old. - Ability to understand the trial information. - Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy. - Elective surgery. - One year potential follow-up. - Patients that experience one or more of the following Trocar Site Hernia risk factors: - Over 60 years old. - Obesity, defined as Body Mass Index (BMI) > 30 Kg/m2. - Diabetes mellitus (DM). - Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year. - Accept to participate in the study and sign the informed consent. Exclusion Criteria: - Contraindication to conduct a laparoscopic cholecystectomy. - Patients with previous open supramesocolic surgery. - Patients with previous surgery that affects the umbilical region. - Patients with umbilical hernia or history of umbilical hernia surgical correction. - A greater than 30 cm xifo-umbilical distance. - Extreme obesity (Body Mass Index > 50 kg/m2). - Cancer patients or in immunosuppressive therapy. - Connective tissue disease.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Infraumbilical Hasson trocar incision
Infraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision
Supraumbilical Hasson trocar incision

Locations

Country Name City State
Spain La Mancha Centro General Hospital Alcázar de San Juan Ciudad Real
Spain Tomelloso General Hospital Tomelloso Ciudad Real
Spain Valdepeñas General Hospital Valdepeñas Ciudad Real

Sponsors (1)

Lead Sponsor Collaborator
Complejo Hospitalario La Mancha Centro

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Trocar site hernia Number of patients presenting a trocar site hernia, at the periumbilical incision, one year after laparoscopic cholecystectomy. One year
Secondary Umbilical wound complications different from Trocar Site Hernia Infection, seroma or ecchymosis at the umbilical wound 24 hours, 7 days, 30 days, 6 months and 1 year.
Secondary Non-umbilical wounds complications Hernia, infection, seroma, ecchymosis or evisceration at non-umbilical wounds. 24 hours, 7 days, 30 days, 6 months and 1 year.
Secondary Other complications Other complications not related to the surgical wound 24 hours, 7 days, 30 days, 6 months and 1 year.
Secondary Surgical time Measured in minutes from the first incision until the complete closure of the last surgical wound Day 0
Secondary Conversion Conversion rate to open surgery (yes/no). Day 0
Secondary Hospital stay Measured in hours from the surgery to the patient discharge. Day 0
Secondary Postoperative pain Measured using the Visual Analogue Scale (VAS), with a punctuation between 0 (no pain) and 10 (the worst conceivable pain). 24 hours and 7 days after surgery.
Secondary Perceived Quality of Life Measured using the SF-36 questionnaire, baseline, one month and a year after surgery.
Secondary Aesthetic result Measured using the Visual Analogue Scale, with a punctuation between 0 (not at all satisfied) and 10 (maximum satisfaction). Six months and a year of the surgery.
See also
  Status Clinical Trial Phase
Recruiting NCT06016426 - Mass Closure vs Layer by Layer Closure N/A
Recruiting NCT05734222 - Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias N/A
Enrolling by invitation NCT03105895 - Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI N/A
Completed NCT01961687 - A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair. N/A
Completed NCT02089958 - Standardization of Laparoscopic Hernia Repair N/A
Completed NCT00998907 - PDS*Plus and Wound Infections After Laparotomy N/A
Terminated NCT00498810 - COMplete Versus PArtial Open inCisional Hernia Repair (COMPAC-TRIAL) N/A
Completed NCT04961346 - RCT Comparing Lightweight vs. Heavyweight Meshes in Incisional Hernia Repair N/A
Terminated NCT03912662 - ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention N/A
Recruiting NCT05620121 - ACute Treatment of Incisional Ventral Hernia
Recruiting NCT03561727 - Risk Factors for Development of Incisional Hernia in Transverse Incisions N/A
Completed NCT03938688 - Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation N/A
Not yet recruiting NCT05568238 - Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen N/A
Not yet recruiting NCT02896686 - Efficacy of an Onlay Mesh for Prevention of Incisional Hernia After Loop Ileostomy Closure Phase 4
Recruiting NCT02277262 - PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM) Phase 4
Active, not recruiting NCT02328352 - "BP as a New Device for Surgery and Solid Cancer and Hematopoietic System Tumors Treatment. Effects of BP Implantation" Phase 1/Phase 2
Suspended NCT01520168 - Composix Kugel Mesh Recall Leaves Unresolved Problems of Patient Management N/A
Completed NCT05579652 - Change in Fascial Tension in Open Abdomens
Active, not recruiting NCT03390764 - Hernia After Colorectal Cancer Surgery N/A
Completed NCT02321059 - Validation of the Goodstrength System for Assessment of Abdominal Wall Strength in Patients With Incisional Hernia N/A